Prime Medicine, Inc. - 8-K Filing

Arbitration tribunal ruled in favor of Prime Medicine regarding PM647 and its compliance with the 2019 Collaboration and License Agreement (Items: 8.01 Other Events On July 6, 2026, Prime Medicine, Inc)

SEC EDGAR ·

Tickers: $PRME

Read the full article at SEC EDGAR

More Regulatory news